Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/11131
Title: [125I][D-Tyr25,Nle28,31]CCK-(25-33): a convenient new aminopeptidase resistant cholecystokinin analogue for radioligand binding and autoradiography.
Austin Authors: Carlberg, M;Beart, P M;Jarrott, B
Affiliation: University of Melbourne, Clinical Pharmacology and Therapeutics Unit, Austin Hospital, Heidelberg, Victoria, Australia
Issue Date: 20-Nov-1990
Publication information: European Journal of Pharmacology; 191(1): 107-10
Abstract: The 125I-labeled sulfated cholecystokinin (CCK) analogue, [D-Tyr25,Nle28,31]CCK-(25-33), bound saturably to membranes from rat cerebral cortex and to brain tissue sections. Competition studies suggested binding to sites of the CCKB subtypes. The high affinity for brain membranes (Kd = 0.14 nM) and high specific binding to brain sections (80-90% specific binding), as well as its high specific radioactivity, makes it a suitable ligand for autoradiographic studies of cholecystokinin receptors.
Gov't Doc #: 2092997
URI: https://ahro.austin.org.au/austinjspui/handle/1/11131
Journal: European Journal of Pharmacology
URL: https://pubmed.ncbi.nlm.nih.gov/2092997
Type: Journal Article
Subjects: Aminopeptidases.metabolism
Animals
Autoradiography
Brain.metabolism
Cholecystokinin.analogs & derivatives.metabolism
In Vitro Techniques
Kinetics
Male
Peptide Fragments.metabolism
Radioligand Assay
Rats
Rats, Inbred Strains
Receptors, Cholecystokinin.metabolism
Appears in Collections:Journal articles

Show full item record

Page view(s)

52
checked on Dec 26, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.